{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:35:22Z","timestamp":1776900922191,"version":"3.51.2"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43533-5","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T16:18:36Z","timestamp":1773245916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deciphering novel genotypic biomarkers and functional alterations in double strand break repair pathways for Parkinson\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Chao-Hsuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Wen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Shin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Kuei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Der-Yang","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Tian","family":"Bau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"43533_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris, H. R., Spillantini, M. G., Sue, C. M. & Williams-Gray, C. H. The pathogenesis of Parkinson\u2019s disease. Lancet 403, 293\u2013304. https:\/\/doi.org\/10.1016\/S0140-6736(23)01478-2 (2024).","journal-title":"Lancet"},{"key":"43533_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo, Y. et al. The epidemiology of Parkinson\u2019s disease. Lancet 403, 283\u2013292. https:\/\/doi.org\/10.1016\/S0140-6736(23)01419-8 (2024).","journal-title":"Lancet"},{"key":"43533_CR3","doi-asserted-by":"publisher","first-page":"1498756","DOI":"10.3389\/fnagi.2024.1498756","volume":"16","author":"Y Luo","year":"2024","unstructured":"Luo, Y. et al. Global, regional, national epidemiology and trends of Parkinson\u2019s disease from 1990 to 2021: findings from the Global Burden of Disease Study 2021. Front. Aging Neurosci. 16, 1498756. https:\/\/doi.org\/10.3389\/fnagi.2024.1498756 (2024).","journal-title":"Front. Aging Neurosci."},{"key":"43533_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa, E., Garrido, A., Scholz, S. W. & Poewe, W. Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol. 20, 385\u2013397. https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2 (2021).","journal-title":"Lancet Neurol."},{"key":"43533_CR5","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3 (2015).","journal-title":"Lancet"},{"key":"43533_CR6","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.14336\/AD.2022.0216","volume":"13","author":"YL Li","year":"2022","unstructured":"Li, Y. L., Wang, Z. X., Ying, C. Z., Zhang, B. R. & Pu, J. L. Decoding the Role of Familial Parkinson\u2019s Disease-Related Genes in DNA Damage and Repair. Aging Dis. 13, 1405\u20131412. https:\/\/doi.org\/10.14336\/AD.2022.0216 (2022).","journal-title":"Aging Dis."},{"key":"43533_CR7","doi-asserted-by":"publisher","first-page":"135203","DOI":"10.1016\/j.neulet.2020.135203","volume":"735","author":"NS Aslan","year":"2020","unstructured":"Aslan, N. S., Orhan, G. & Karahalil, B. The impacts of prominent gene polymorphisms in DNA repair enzymes on Parkinson\u2019s disease. Neurosci. Lett. 735, 135203. https:\/\/doi.org\/10.1016\/j.neulet.2020.135203 (2020).","journal-title":"Neurosci. Lett."},{"key":"43533_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/jnr.24592","volume":"99","author":"CP Gonzalez-Hunt","year":"2021","unstructured":"Gonzalez-Hunt, C. P. & Sanders, L. H. DNA damage and repair in Parkinson\u2019s disease: Recent advances and new opportunities. J. Neurosci. Res. 99, 180\u2013189. https:\/\/doi.org\/10.1002\/jnr.24592 (2021).","journal-title":"J. Neurosci. Res."},{"key":"43533_CR9","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.celrep.2016.04.071","volume":"15","author":"S Sepe","year":"2016","unstructured":"Sepe, S. et al. Inefficient DNA Repair Is an Aging-Related Modifier of Parkinson\u2019s Disease. Cell. Rep. 15, 1866\u20131875. https:\/\/doi.org\/10.1016\/j.celrep.2016.04.071 (2016).","journal-title":"Cell. Rep."},{"key":"43533_CR10","doi-asserted-by":"publisher","first-page":"852002","DOI":"10.3389\/fncel.2022.852002","volume":"16","author":"X Li","year":"2022","unstructured":"Li, X. et al. Polymerases and DNA Repair in Neurons: Implications in Neuronal Survival and Neurodegenerative Diseases. Front. Cell. Neurosci. 16, 852002. https:\/\/doi.org\/10.3389\/fncel.2022.852002 (2022).","journal-title":"Front. Cell. Neurosci."},{"key":"43533_CR11","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3390\/antiox12040955","volume":"12","author":"S Chakrabarti","year":"2023","unstructured":"Chakrabarti, S. & Bisaglia, M. Oxidative Stress and Neuroinflammation in Parkinson\u2019s Disease: The Role of Dopamine Oxidation Products. Antioxid. (Basel). 12, 955. https:\/\/doi.org\/10.3390\/antiox12040955 (2023).","journal-title":"Antioxid. (Basel)"},{"key":"43533_CR12","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/ijms17060954","volume":"17","author":"M Ogino","year":"2016","unstructured":"Ogino, M. et al. Roles of PTEN with DNA Repair in Parkinson\u2019s Disease. Int. J. Mol. Sci. 17, 954. https:\/\/doi.org\/10.3390\/ijms17060954 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"43533_CR13","doi-asserted-by":"publisher","first-page":"146342","DOI":"10.1016\/j.brainres.2019.146342","volume":"1722","author":"J Kim","year":"2019","unstructured":"Kim, J. & Daadi, M. M. Non-cell autonomous mechanism of Parkinson\u2019s disease pathology caused by G2019S LRRK2 mutation in Ashkenazi Jewish patient: Single cell analysis. Brain Res. 1722, 146342. https:\/\/doi.org\/10.1016\/j.brainres.2019.146342 (2019).","journal-title":"Brain Res."},{"key":"43533_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.nbd.2013.10.013","volume":"62","author":"LH Sanders","year":"2014","unstructured":"Sanders, L. H. et al. LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson\u2019s disease patients: reversal by gene correction. Neurobiol. Dis. 62, 381\u2013386. https:\/\/doi.org\/10.1016\/j.nbd.2013.10.013 (2014).","journal-title":"Neurobiol. Dis."},{"key":"43533_CR15","doi-asserted-by":"publisher","first-page":"e19807","DOI":"10.7717\/peerj.19807","volume":"13","author":"MH Che Lah","year":"2025","unstructured":"Che Lah, M. H., Reza, F., Shamsuddin, M., Watanabe, S., Abdullah, J. M. & I. & Systematic review of electron transfer study in DNA relevant to Parkinson\u2019s disease and scanning tunneling microscopy. PeerJ 13, e19807. https:\/\/doi.org\/10.7717\/peerj.19807 (2025).","journal-title":"PeerJ"},{"key":"43533_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1242\/bio.022186","volume":"6","author":"S Lehmann","year":"2017","unstructured":"Lehmann, S., Loh, S. H., Martins, L. M. & Enhancing NAD(+) salvage metabolism is neuroprotective in a PINK1 model of Parkinson\u2019s disease. Biol. Open. 6, 141\u2013147. https:\/\/doi.org\/10.1242\/bio.022186 (2017).","journal-title":"Biol. Open."},{"key":"43533_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2012.674182","volume":"30","author":"CY Chen","year":"2012","unstructured":"Chen, C. Y. Mechanism of BAG1 repair on Parkinson\u2019s disease-linked DJ1 mutation. J. Biomol. Struct. Dyn. 30, 1\u201312. https:\/\/doi.org\/10.1080\/07391102.2012.674182 (2012).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"43533_CR18","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.21873\/anticanres.14299","volume":"40","author":"A Ayimugu","year":"2020","unstructured":"Ayimugu, A., Sarihan, M., Kasap, M. & Akpinar, G. Investigation of the Involvement of Parkin in Parkinson\u2019s Disease and Cancer by Monitoring the Changes in SH-SY5Y Cells at the Nuclear Proteome Level. Anticancer Res. 40, 3169\u20133190. https:\/\/doi.org\/10.21873\/anticanres.14299 (2020).","journal-title":"Anticancer Res."},{"key":"43533_CR19","doi-asserted-by":"publisher","first-page":"e13163","DOI":"10.1111\/acel.13163","volume":"19","author":"K Mao","year":"2020","unstructured":"Mao, K. et al. Poly (ADP-ribose) polymerase 1 inhibition prevents neurodegeneration and promotes alpha-synuclein degradation via transcription factor EB-dependent autophagy in mutant alpha-synucleinA53T model of Parkinson\u2019s disease. Aging Cell. 19, e13163. https:\/\/doi.org\/10.1111\/acel.13163 (2020).","journal-title":"Aging Cell."},{"key":"43533_CR20","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1089\/gtmb.2011.0252","volume":"16","author":"M Gencer","year":"2012","unstructured":"Gencer, M. et al. DNA repair genes in Parkinson\u2019s disease. Genet. Test. Mo l Biomarkers. 16, 504\u2013507. https:\/\/doi.org\/10.1089\/gtmb.2011.0252 (2012).","journal-title":"Genet. Test. Mo l Biomarkers"},{"key":"43533_CR21","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3390\/brainsci15091008","volume":"15","author":"KM Alvarado-Retana","year":"2025","unstructured":"Alvarado-Retana, K. M. et al. Sex-Specific Association Between XPC rs2228001 Polymorphism and Parkinson\u2019s Disease Risk in a Mexican Population: A Case-Control Study Exploring Gene-Environment Interactions. Brain Sci. 15, 1008. https:\/\/doi.org\/10.3390\/brainsci15091008 (2025).","journal-title":"Brain Sci."},{"key":"43533_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/toxsci\/kfx086","volume":"158","author":"L. H. Sanders","year":"2017","unstructured":"Sanders, L. H. et al. (eds) \u2018s Highlight: Base Excision Repair Variants and Pesticide Exposure Increase Parkinson\u2019s Disease Risk. Toxicol. Sci. 158, 188\u2013198. https:\/\/doi.org\/10.1093\/toxsci\/kfx086 (2017).","journal-title":"Toxicol. Sci."},{"key":"43533_CR23","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"M. G. Spillantini","year":"1998","unstructured":"Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. USA 95, 6469\u20136473 https:\/\/doi.org\/10.1073\/pnas.95.11.6469 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"43533_CR24","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba, M. et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Am. J. Pathol. 152, 879\u2013884 (1998).","journal-title":"Am. J. Pathol."},{"key":"43533_CR25","doi-asserted-by":"publisher","first-page":"eadq2519","DOI":"10.1126\/sciadv.adq2519","volume":"11","author":"MR Arnold","year":"2025","unstructured":"Arnold, M. R. et al. Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanoma. Sci. Adv. 11, eadq2519. https:\/\/doi.org\/10.1126\/sciadv.adq2519 (2025).","journal-title":"Sci. Adv."},{"key":"43533_CR26","doi-asserted-by":"publisher","first-page":"10919","DOI":"10.1038\/s41598-019-47227-z","volume":"9","author":"AJ Schaser","year":"2019","unstructured":"Schaser, A. J. et al. Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders. Sci. Rep. 9, 10919. https:\/\/doi.org\/10.1038\/s41598-019-47227-z (2019).","journal-title":"Sci. Rep."},{"key":"43533_CR27","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.3390\/ijms24065612","volume":"24","author":"B Otahalova","year":"2023","unstructured":"Otahalova, B. et al. Importance of Germline and Somatic Alterations in Human MRE11, RAD50, and NBN Genes Coding for MRN Complex. Int. J. Mol. Sci. 24, 5612. https:\/\/doi.org\/10.3390\/ijms24065612 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"43533_CR28","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1002\/ijc.35066","volume":"155","author":"B Stastna","year":"2024","unstructured":"Stastna, B. et al. Germline pathogenic variants in the MRE11, RAD50, and NBN (MRN) genes in cancer predisposition: A systematic review and meta-analysis. Int. J. Cancer. 155, 1604\u20131615. https:\/\/doi.org\/10.1002\/ijc.35066 (2024).","journal-title":"Int. J. Cancer"},{"key":"43533_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/cells8020151","volume":"8","author":"D Richter","year":"2019","unstructured":"Richter, D. et al. Dynamics of Parkinson\u2019s Disease Multimodal Complex Treatment in Germany from 2010(-)2016: Patient Characteristics, Access to Treatment, and Formation of Regional Centers. Cells 8, 151. https:\/\/doi.org\/10.3390\/cells8020151 (2019).","journal-title":"Cells"},{"key":"43533_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1051\/bmdcn\/2017070203","volume":"7","author":"MD Yang","year":"2017","unstructured":"Yang, M. D. et al. Contribution of matrix metalloproteinases-1 genotypes to gastric cancer susceptibility in Taiwan. Biomed. (Taipei). 7, 10. https:\/\/doi.org\/10.1051\/bmdcn\/2017070203 (2017).","journal-title":"Biomed. (Taipei)"},{"key":"43533_CR31","first-page":"529","volume":"30","author":"KH Wu","year":"2010","unstructured":"Wu, K. H. et al. Significant association of XRCC4 single nucleotide polymorphisms with childhood leukemia in Taiwan. Anticancer Res. 30, 529\u2013533 (2010).","journal-title":"Anticancer Res."},{"key":"43533_CR32","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.oraloncology.2007.11.007","volume":"44","author":"CF Chiu","year":"2008","unstructured":"Chiu, C. F. et al. A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol. 44, 898\u2013902. https:\/\/doi.org\/10.1016\/j.oraloncology.2007.11.007 (2008).","journal-title":"Oral Oncol."},{"key":"43533_CR33","first-page":"1687","volume":"28","author":"HC Tseng","year":"2008","unstructured":"Tseng, H. C. et al. Association of XRCC4 codon 247 polymorphism with oral cancer susceptibility in Taiwan. Anticancer Res. 28, 1687\u20131691 (2008).","journal-title":"Anticancer Res."},{"key":"43533_CR34","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.oraloncology.2008.12.002","volume":"45","author":"CF Hsu","year":"2009","unstructured":"Hsu, C. F. et al. Association between DNA double strand break gene Ku80 polymorphisms and oral cancer susceptibility. Oral Oncol. 45, 789\u2013793. https:\/\/doi.org\/10.1016\/j.oraloncology.2008.12.002 (2009).","journal-title":"Oral Oncol."},{"key":"43533_CR35","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.ijom.2015.06.008","volume":"44","author":"CY Huang","year":"2015","unstructured":"Huang, C. Y. et al. The role of XRCC6\/Ku70 in nasopharyngeal carcinoma. Int. J. Oral Maxillofac. Surg. 44, 1480\u20131485. https:\/\/doi.org\/10.1016\/j.ijom.2015.06.008 (2015).","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"43533_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.21873\/invivo.13419","volume":"38","author":"Y. Deng","year":"2024","unstructured":"Deng, Y. et al. The contribution of DNA Ligase 4 polymorphisms to colorectal cancer. Vivo 38, 127\u2013133. https:\/\/doi.org\/10.21873\/invivo.13419 (2024).","journal-title":"Vivo"},{"key":"43533_CR37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.21873\/cgp.20436","volume":"21","author":"CC Chen","year":"2024","unstructured":"Chen, C. C. et al. Non-homologous End-joining Genotype, mRNA Expression, and DNA Repair Capacity in Childhood Acute Lymphocytic Leukemia. Cancer Genomics Proteom. 21, 144\u2013157. https:\/\/doi.org\/10.21873\/cgp.20436 (2024).","journal-title":"Cancer Genomics Proteom."},{"key":"43533_CR38","doi-asserted-by":"publisher","unstructured":"Chang, S. Y. et al. Genetic Variations in MDM2 Gene Contribute to Renal Cell Carcinoma Susceptibility: A Genotype-Phenotype Correlation Study. Cancers (Basel). 17 https:\/\/doi.org\/10.3390\/cancers17020177 (2025).","DOI":"10.3390\/cancers17020177"},{"key":"43533_CR39","doi-asserted-by":"publisher","unstructured":"Wang, B. R. et al. Contribution of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 to Upper Tract Urothelial Cancer Risk in Taiwan. Life (Basel). 14 https:\/\/doi.org\/10.3390\/life14070801 (2024).","DOI":"10.3390\/life14070801"},{"key":"43533_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2203\/dose-response.09-001.Singh","volume":"7","author":"S Singh","year":"2009","unstructured":"Singh, S., Bala, M., Kumar, R., Kumar, A. & Dhiman, S. C. Modification in the expression of Mre11\/Rad50\/Nbs1 complex in low dose irradiated human lymphocytes. Dose Response. 7, 193\u2013207. https:\/\/doi.org\/10.2203\/dose-response.09-001.Singh (2009).","journal-title":"Dose Response"},{"key":"43533_CR41","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3390\/biomedicines11061648","volume":"11","author":"C. W. Tsai","year":"2023","unstructured":"Tsai, C. W. et al. Non-Homologous End-Joining Pathway Genotypes Significantly Associated with Nasopharyngeal Carcinoma Susceptibility. Biomedicines 11, 1648. https:\/\/doi.org\/10.3390\/biomedicines11061648 (2023).","journal-title":"Biomedicines"},{"key":"43533_CR42","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1006\/jmbi.1999.3310","volume":"294","author":"N Blom","year":"1999","unstructured":"Blom, N., Gammeltoft, S. & Brunak, S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294, 1351\u20131362. https:\/\/doi.org\/10.1006\/jmbi.1999.3310 (1999).","journal-title":"J. Mol. Biol."},{"key":"43533_CR43","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. Royal Stat. Soc. Ser. B (Methodological). 57, 289\u2013300 (1995). http:\/\/www.jstor.org\/stable\/2346101","journal-title":"J. Royal Stat. Soc. Ser. B (Methodological)"},{"key":"43533_CR44","doi-asserted-by":"publisher","first-page":"101078","DOI":"10.1016\/j.lanwpc.2024.101078","volume":"46","author":"T Xu","year":"2024","unstructured":"Xu, T. et al. Disease burden of Parkinson\u2019s disease in China and its provinces from 1990 to 2021: findings from the global burden of disease study 2021. Lancet Reg. Health West. Pac. 46, 101078. https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101078 (2024).","journal-title":"Lancet Reg. Health West. Pac."},{"key":"43533_CR45","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.3390\/biomedicines10123247","volume":"10","author":"A. Montori","year":"2022","unstructured":"Montori, A. et al. Somatic NGS Analysis of DNA Damage Response (DDR) MRE11A, RAD50, NBN, and ATR in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemo-Radiotherapy. Biomedicines 10, 3247 https:\/\/doi.org\/10.3390\/biomedicines10123247 (2022).","journal-title":"Biomedicines"},{"key":"43533_CR46","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/s0092-8674(00)81174-5","volume":"93","author":"R Varon","year":"1998","unstructured":"Varon, R. et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93, 467\u2013476. https:\/\/doi.org\/10.1016\/s0092-8674(00)81174-5 (1998).","journal-title":"Cell"},{"key":"43533_CR47","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41580-020-00297-8","volume":"21","author":"B Zhao","year":"2020","unstructured":"Zhao, B., Rothenberg, E., Ramsden, D. A. & Lieber, M. R. The molecular basis and disease relevance of non-homologous DNA end joining. Nat. Rev. Mol. Cell. Biol. 21, 765\u2013781. https:\/\/doi.org\/10.1038\/s41580-020-00297-8 (2020).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"43533_CR48","doi-asserted-by":"publisher","first-page":"102874","DOI":"10.1016\/j.dnarep.2020.102874","volume":"94","author":"XS Wang","year":"2020","unstructured":"Wang, X. S., Lee, B. J. & Zha, S. The recent advances in non-homologous end-joining through the lens of lymphocyte development. DNA Repair. (Amst). 94, 102874. https:\/\/doi.org\/10.1016\/j.dnarep.2020.102874 (2020).","journal-title":"DNA Repair. (Amst)"},{"key":"43533_CR49","first-page":"529","volume":"33","author":"CM Hsu","year":"2013","unstructured":"Hsu, C. M. et al. The contribution of XRCC6\/Ku70 to hepatocellular carcinoma in Taiwan. Anticancer Res. 33, 529\u2013535 (2013).","journal-title":"Anticancer Res."},{"key":"43533_CR50","first-page":"3855","volume":"32","author":"WS Chang","year":"2012","unstructured":"Chang, W. S. et al. The role of XRCC6 T-991\u00a0C functional polymorphism in renal cell carcinoma. Anticancer Res. 32, 3855\u20133860 (2012).","journal-title":"Anticancer Res."},{"key":"43533_CR51","doi-asserted-by":"publisher","first-page":"4972","DOI":"10.3390\/cancers15204972","volume":"15","author":"D Butkiewicz","year":"2023","unstructured":"Butkiewicz, D., Krzesniak, M., Gdowicz-Klosok, A., Skladowski, K. & Rutkowski, T. D. N. A. Double-Strand Break Response and Repair Gene Polymorphisms May Influence Therapy Results and Prognosis in Head and Neck Cancer Patients. Cancers (Basel). 15, 4972. https:\/\/doi.org\/10.3390\/cancers15204972 (2023).","journal-title":"Cancers (Basel)"},{"key":"43533_CR52","doi-asserted-by":"publisher","first-page":"e20200160","DOI":"10.1590\/1678-4685-GMB-2020-0160","volume":"43","author":"O Louzada-Neto","year":"2020","unstructured":"Louzada-Neto, O. et al. XRCC4 rs28360071 intronic variant is associated with increased risk for infant acute lymphoblastic leukemia with KMT2A rearrangements. Genet. Mol. Biol. 43, e20200160. https:\/\/doi.org\/10.1590\/1678-4685-GMB-2020-0160 (2020).","journal-title":"Genet. Mol. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43533-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43533-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43533-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T22:37:50Z","timestamp":1776897470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43533-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43533"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43533-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13173"}}